These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19689042)

  • 1. [The importance of angiogenesis in pancreatic cancer].
    Myśliwiec P; Dadan J
    Przegl Lek; 2009; 66(3):155-8. PubMed ID: 19689042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-angiogenesis therapy in pancreatic carcinoma.
    Saif MW
    JOP; 2006 Mar; 7(2):163-73. PubMed ID: 16525200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia and angiogenesis in pancreatic cancer.
    Garcea G; Doucas H; Steward WP; Dennison AR; Berry DP
    ANZ J Surg; 2006 Sep; 76(9):830-42. PubMed ID: 16922908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational research in pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
    Strimpakos AS; Syrigos KN; Saif MW
    JOP; 2010 Mar; 11(2):124-7. PubMed ID: 20208318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis and antiangiogenic strategies in pancreatic cancer.
    Fisher WE; Berger DH
    Int J Gastrointest Cancer; 2003; 33(1):79-88. PubMed ID: 12909740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging drugs in the treatment of pancreatic cancer.
    Mahalingam D; Kelly KR; Swords RT; Carew J; Nawrocki ST; Giles FJ
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):311-28. PubMed ID: 19466902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics and pancreatic cancer treatment. Optimizing current therapy and individualizing future therapy.
    Kang SP; Saif MW
    JOP; 2008 May; 9(3):251-66. PubMed ID: 18469437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic drugs in ovarian cancer.
    Markman M
    Expert Opin Pharmacother; 2009 Oct; 10(14):2269-77. PubMed ID: 19671017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis in pancreatic cancer: current research status and clinical implications.
    Li S; Xu HX; Wu CT; Wang WQ; Jin W; Gao HL; Li H; Zhang SR; Xu JZ; Qi ZH; Ni QX; Yu XJ; Liu L
    Angiogenesis; 2019 Feb; 22(1):15-36. PubMed ID: 30168025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer therapy: current, future and anti-angiogensis targeted treatment.
    Willmott LJ; Monk BJ
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):895-903. PubMed ID: 19589029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic carcinogenesis: apoptosis and angiogenesis.
    Onizuka S; Kawakami S; Taniguchi K; Fujioka H; Miyashita K
    Pancreas; 2004 Apr; 28(3):317-9. PubMed ID: 15084979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic strategies in pancreatic cancer.
    Riess H
    Recent Results Cancer Res; 2008; 177():123-9. PubMed ID: 18084954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
    Miller RC; Iott MJ; Corsini MM
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological and therapeutic significance of tissue transglutaminase in pancreatic cancer.
    Mehta K
    Amino Acids; 2009 Apr; 36(4):709-16. PubMed ID: 18594944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of S-1 therapy for unresectable/advanced pancreas cancer].
    Kanbe T; Kishimoto Y; Tsunoda H; Imamoto R; Mukouyama T; Nishimuki E; Shabana M; Kojo H
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1475-80. PubMed ID: 19755815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital mortality after pancreatic resection for chronic pancreatitis: population-based estimates from the nationwide inpatient sample.
    Hill JS; McPhee JT; Whalen GF; Sullivan ME; Warshaw AL; Tseng JF
    J Am Coll Surg; 2009 Oct; 209(4):468-76. PubMed ID: 19801320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations in improving detection of pancreatic adenocarcinoma.
    Mendieta Zerón H; García Flores JR; Romero Prieto ML
    Future Oncol; 2009 Jun; 5(5):657-68. PubMed ID: 19519205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of targeted therapies in ovarian cancer.
    Banerjee S; Gore M
    Oncologist; 2009 Jul; 14(7):706-16. PubMed ID: 19592450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing tumor angiogenesis: lessons from VEGF-resistant tumors and wounds.
    Cuevas I; Boudreau N
    Adv Cancer Res; 2009; 103():25-42. PubMed ID: 19854351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in the treatment of locally advanced pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
    Triano LR; Chang BW; Saif MW
    JOP; 2009 Jul; 10(4):366-72. PubMed ID: 19581736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.